FDA To Unveil Strategy To Split MPX Vaccine Doses

The Washington Post reports:

Biden administration officials are set to announce Tuesday a new strategy to split monkeypox vaccine doses in hopes of vaccinating up to five times as many people against the virus, according to officials with direct knowledge of the plan.

Rather than inject doses of Jynneos subcutaneously, a traditional way of delivering vaccines into the fatty tissue under the skin, the doses would instead be injected under the top layer of the skin.

This approach, known as an intradermal injection, uses a thinner needle and less vaccine, but leads to a small bubble forming on the surface of the skin that can scar.

Read the full article. The FDA says the change will not compromise the efficacy of the vaccine.

Biden administration officials are set to announce Tuesday a new strategy to split monkeypox vaccine doses in hopes of vaccinating up to five times as many people against the virus, according to officials with direct knowledge of the plan. https://t.co/PuEIScPwjT

— The Washington Post (@washingtonpost) August 9, 2022